Anna C. Need

Anna C. Need

Auto-generated profile, based on publicly available information

Anna C. Need

Division of Brain Sciences, Department of Medicine, Imperial College, London, SW7 2AZ, UK

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 September 2008 in Nature
Verified
Journal Article
Closed access
PDF file
GRGROUP
GROUP
HSHreinn Stefansson
Hreinn Stefansson
DRDan Rujescu
Dan Rujescu
SCSven Cichon
Sven Cichon
OPOlli P. H. Pietiläinen
Olli P. H. Pietiläinen
KSKari Stefansson
Kari Stefansson

1 July 2009 in Nature
Verified
Journal Article
Closed access
PDF file
†(†Genetic Risk and Outcome in Psychosis (GROUP)
†Genetic Risk and Outcome in Psychosis (GROUP)
HSHreinn Stefansson
Hreinn Stefansson
RORoel A. Ophoff
Roel A. Ophoff
SSStacy Steinberg
Stacy Steinberg
OAOle A. Andreassen
Ole A. Andreassen
DCDavid A. Collier
David A. Collier

25 June 2018 in Nature Genetics
Verified
Journal Article
Open access
PDF file
JSJeanne E. Savage
Jeanne E. Savage
PJPhilip R. Jansen
Philip R. Jansen
SSSven Stringer
Sven Stringer
KWKyoko Watanabe
Kyoko Watanabe
JBJulien Bryois
Julien Bryois
DPDanielle Posthuma
Danielle Posthuma
Intelligence is highly heritable1 and a major determinant of human health and well-being2. Recent genome-wide meta-analyses have identified 24 genomic loci linked to variation in intelligence3,4,5,6,7, but much about its genetic underpinnings remains to be discovered. Here, we present a large-scale genetic association study of intelligence (n = 269,867), identifying 205 associated genomic loci (190 new) and 1,016 genes (939 new) via positional mapping, expression quantitative trait locus (eQTL) mapping, chromatin interaction mapping, and gene-based association analysis. We find enrichment of genetic effects in conserved and coding regions and associations with 146 nonsynonymous exonic variants. Associated genes are strongly expressed in the brain, specifically in striatal medium spiny neurons and hippocampal pyramidal neurons. Gene set analyses implicate pathways related to nervous system development and synaptic structure. We confirm previous strong genetic correlations with multiple health-related outcomes, and Mendelian randomization analysis results suggest protective effects of intelligence for Alzheimer’s disease and ADHD and bidirectional causation with pleiotropic effects for schizophrenia. These results are a major step forward in understanding the neurobiology of cognitive function as well as genetically related neurological and psychiatric disorders.

29 May 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
GDGail Davies
Gail Davies
MLMax Lam
Max Lam
SHSarah E Harris
Sarah E Harris
JTJoey W Trampush
Joey W Trampush
MLMichelle Luciano
Michelle Luciano
IDIan Deary
Ian Deary
General cognitive function is a prominent and relatively stable human trait that is associated with many important life outcomes. We combine cognitive and genetic data from the CHARGE and COGENT consortia, and UK Biobank (totalN = 300,486; age 16–102) and find 148 genome-wide significant independent loci (P < 5 × 10−8) associated with general cognitive function. Within the novel genetic loci are variants associated with neurodegenerative and neurodevelopmental disorders, physical and psychiatric illnesses, and brain structure. Gene-based analyses find 709 genes associated with general cognitive function. Expression levels across the cortex are associated with general cognitive function. Using polygenic scores, up to 4.3% of variance in general cognitive function is predicted in independent samples. We detect significant genetic overlap between general cognitive function, reaction time, and many health variables including eyesight, hypertension, and longevity. In conclusion we identify novel genetic loci and pathways contributing to the heritability of general cognitive function.

20 March 2009 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
SPSreekumar G. Pillai
Sreekumar G. Pillai
DGDongliang Ge
Dongliang Ge
GZGuohua Zhu
Guohua Zhu
XKXiangyang Kong
Xiangyang Kong
KSKevin V. Shianna
Kevin V. Shianna
DGDavid B. Goldstein
David B. Goldstein
There is considerable variability in the susceptibility of smokers to develop chronic obstructive pulmonary disease (COPD). The only known genetic risk factor is severe deficiency of α1-antitrypsin, which is present in 1–2% of individuals with COPD. We conducted a genome-wide association study (GWAS) in a homogenous case-control cohort from Bergen, Norway (823 COPD cases and 810 smoking controls) and evaluated the top 100 single nucleotide polymorphisms (SNPs) in the family-based International COPD Genetics Network (ICGN; 1891 Caucasian individuals from 606 pedigrees) study. The polymorphisms that showed replication were further evaluated in 389 subjects from the US National Emphysema Treatment Trial (NETT) and 472 controls from the Normative Aging Study (NAS) and then in a fourth cohort of 949 individuals from 127 extended pedigrees from the Boston Early-Onset COPD population. Logistic regression models with adjustments of covariates were used to analyze the case-control populations. Family-based association analyses were conducted for a diagnosis of COPD and lung function in the family populations. Two SNPs at the α-nicotinic acetylcholine receptor (CHRNA 3/5) locus were identified in the genome-wide association study. They showed unambiguous replication in the ICGN family-based analysis and in the NETT case-control analysis with combined p-values of 1.48×10−10, (rs8034191) and 5.74×10−10 (rs1051730). Furthermore, these SNPs were significantly associated with lung function in both the ICGN and Boston Early-Onset COPD populations. The C allele of the rs8034191 SNP was estimated to have a population attributable risk for COPD of 12.2%. The association of hedgehog interacting protein (HHIP) locus on chromosome 4 was also consistently replicated, but did not reach genome-wide significance levels. Genome-wide significant association of the HHIP locus with lung function was identified in the Framingham Heart study (Wilk et al., companion article in this issue of PLoS Genetics; doi:10.1371/journal.pgen.1000429). The CHRNA 3/5 and the HHIP loci make a significant contribution to the risk of COPD. CHRNA3/5 is the same locus that has been implicated in the risk of lung cancer. There is considerable variability in the susceptibility of smokers to develop chronic obstructive pulmonary disease (COPD), which is a heritable multi-factorial trait. Identifying the genetic determinants of COPD risk will have tremendous public health importance. This study describes the first genome-wide association study (GWAS) in COPD. We conducted a GWAS in a homogenous case-control cohort from Norway and evaluated the top 100 single nucleotide polymorphisms in the family-based International COPD Genetics Network. The polymorphisms that showed replication were further evaluated in subjects from the US National Emphysema Treatment Trial and controls from the Normative Aging Study and then in a fourth cohort of extended pedigrees from the Boston Early-Onset COPD population. Two polymorphisms in the α-nicotinic acetylcholine receptor 3/5 locus on chromosome 15 showed unambiguous evidence of association with COPD. This locus has previously been implicated in both smoking behavior and risk of lung cancer, suggesting the possibility of multiple functional polymorphisms in the region or a single polymorphism with wide phenotypic consequences. The hedgehog interacting protein (HHIP) locus on chromosome 4, which is associated with COPD, is also a significant risk locus for COPD.

1 July 2008 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
APAlkes L. Price
Alkes L. Price
MWMichael Weale
Michael Weale
NPNick Patterson
Nick Patterson
SMSimon R. Myers
Simon R. Myers
ANAnna C. Need
Anna C. Need
DRDavid Reich
David Reich